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INTRODUCTION*
Strategic Directions in Osteoinduction and Biomimetics
Pamela Habibovic, PhD
Treatment of large, critical-sized bone defects re-mains an important clinical challenge despite the in-
trinsic regenerative capacity of healthy bone tissue. Indeed,
the lack of bone tissue as a result of congenital disorders and
loss of bone tissue caused by trauma or disease represent a
clinical problem affecting more than 20 million people an-
nually worldwide. This leads to about 5 million orthopedic
interventions every year, of which about 60% require bone
grafting to ensure bone growth in defect sites.
Conventional methods of bone repair and regeneration
employ a patient’s own bone graft (autograft) or bone from a
donor (allograft); however, there are a number of disad-
vantages associated with the use of natural bone grafts.1 The
harvest of the graft requires an additional invasive surgical
procedure that may lead to donor site morbidity and chronic
postoperative pain (in up to 18.7% of all patients after 2
years), hypersensitivity, and infection. The most important
disadvantage associated with their use is, however, limited
availability, as the total amount of bone that can be har-
vested from the iliac crest is limited to *5 cc.2
Therefore, an increasing need exists for effective and af-
fordable bone repair strategies. To meet this need, it is im-
portant to develop alternatives for autologous and allogeneic
bone grafts. Although various requirements can be defined that
a successful bone graft substitute should meet, osteoinductivity
is often considered the most critical property in order for the
clinical performance of bone graft substitutes to match that of
natural bone grafts.
Osteoinduction, initially defined by Friedenstein as the
process of the ‘‘induction of undifferentiated inducible os-
teoprogenitor cells that are not yet committed to the osteo-
genic lineage to form osteoprogenitor cells,’’3 was recognized
as an important mechanism in bone repair strategies after the
seminal work by Urist, who showed the ability of hydro-
chloric acid–decalcified diaphyseal bone to induce de novo
bone formation upon intramuscular implantation in various
animal models.4 Further research, focusing on describing the
mechanisms of this heterotopic bone formation, resulted in
the identification of bone morphogenetic proteins (BMPs) as
inducer of the cascade of chemotaxis, mitosis, differentiation,
callus formation, and finally bone formation.5 The fact that
BMPs, with emphasis on commercially available BMP-2
and BMP-7 (OP-1), have shown clinical successes in spinal
fusion and treatment of defects caused by trauma6–8 has
logically strengthened the perception of osteoinduction as
being a highly important property of a bone graft substitute.
As a result, research into new, improved bone graft substi-
tutes is often focused on developing constructs that are os-
teoinductive, while retaining other important properties, such
as mechanical strength, handling properties, or degradability.
Strategies toward this aim are diverse, varying from addition of
osteogenic cells or cells with the potential to differentiate into
the osteogenic lineage to appropriate carrier materials, to the
use of osteoinductive growth factors, molecules, or bioinor-
ganics and the development of smart synthetic biomaterials
capable of triggering de novo bone formation in vivo, by tuning
their physicochemical and structural properties.
In this special issue, many of these different approaches
are covered. In a number of studies, the delivery and the
osteoinductive capacity of BMP-2 were the topic of in-
vestigation. Demineralized bone matrix-based paste was
investigated as a carrier of BMP-2 for controlled delivery
in time, while retaining the osteoinductive capacity (Huber
et al., page 1321). A combined delivery of alendronate and
BMP-2 from a collagen carrier (Cho et al., page 1343), of
platelet-derived growth factor-bb end BMP-2 from a cal-
cium phosphate (CaP)/alginate composite (Bayer et al.,
page 1382), of zoledronic acid and BMP-2 from a com-
mercially available gentamicin-containing calcium sul-
fate/hydroxyapatite composite carrier (Horstmann et al.,
page 1403), and a sequential delivery of fibroblast growth
factor-2 and BMP-2 from layer-by-layer coatings (Gro-
nowicz et al., page 1490) were also investigated in vitro
and in vivo.
Two novel extracellular matrix-like gels, one based on
elastin-like recombinomers, functionalized with BMP-2 or
the Arg-Gly-Asp (RGD) cell adhesion motif (Colletta et al.,
page 1361), and the other on a self-assembling peptide hy-
drogel SBG-178-Gel (Tsukamoto et al., page 1394), were
investigated for their potential to be used in bone regener-
ation, whereas a jelly collagen was supplemented with ly-
sophosphatidic acid and 1a, 25-dihydroxyvitamin D3 to
induce the proliferation, differentiation, and migration of
human primary osteoblasts (Bosetti et al., page 1413).
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In yet another study, chondrogenic priming and mechan-
ical stimulation were investigated as combined tools to induce
the osteogenic differentiation of human mesenchymal stromal
cells (Freeman et al., page 1466).
In two studies, mimicking the process of natural biomi-
neralization was used as an inspiration to develop new bio-
materials for bone regeneration (Ramı́rez-Rodrı́guez et al.,
page 1423; Harding et al., page 1452).
Another set of interesting studies focused on fine-tuning
of physicochemical and structural properties of synthetic
biomaterials, such as CaPs with the aim to improve their
bone regenerative potential. A comparison was made be-
tween biomimetic and sintered CaPs, having different
physicochemical features with regard to their effect on os-
teoblastic and mesenchymal stromal cells (Sadowska et al.,
page 1297) and between two types of moldable CaP-based
bone graft substitutes, differing in their carrier, regarding
their bone-forming capacity in vivo (Barbieri et al., page
1310). In another study, an iron chelator deferoxamine, a
hypoxia mimicker, was used as an additive to 3D printed CaP
implants to stimulate bone formation (Drager et al., page
1372), whereas divalent cations-substituted borosilicate bio-
active glasses were developed and tested for their ability to
induce the osteogenic differentiation and mineralization of
mesenchymal stromal cells (Fernandes et al., page 1331).
Finally, this special issue contains three excellent review
articles. Two of these reviews provide a comprehensive
overview on the potential of extracellular matrices (Mansour
et al., page 1436) and membranes (Caridade and Mano,
page 1502) to be used in bone regeneration, whereas one is
focused on the importance of surface properties, including
hydrophilicity and roughness on peri-implant bone tissue
formation (Boyan et al., page 1479).
Taken together, this special issue provides an overview of
efforts that have been expended to develop effective bone
graft substitutes. Some of these strategies follow a rational
approach aimed at mimicking the composition or structure of
natural bone, or a microenvironment within bone, whereas
other strategies focus on optimizing one property (e.g., ac-
celerating the rate of new bone formation) with the rationale
that, by doing so, other limitations of the material (e.g., poor
mechanical properties) will be compensated.
Regardless of the strategy taken, it is obvious that the
bone regenerative capacity of new bone graft substitutes
needs to match that of the natural grafts, to be fully ac-
cepted as a comprehensive alternative. It is furthermore
important to take into account challenging clinical settings,
including elderly patients and patients with systemic or
chronic diseases that may significantly affect bone regen-
erative potential in such patients. Finally, it is imperative
that the bone regenerative strategies are affordable, to meet
an ever-growing need without presenting a heavy burden
on our healthcare system.
In summary, it is evident that continuing research efforts
in the field of biomaterials and tissue-engineered constructs
for bone regeneration are much needed. This special issue
will hopefully stimulate further work in this area, both from
a fundamental and from a translational perspective.
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